# Mirvaso

NDC: 0299-5980
Generic name: brimonidine tartrate
Labeler / Manufacturer: Galderma Laboratories, L.P.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20130823

FDA application: NDA204708

## Active ingredients

- BRIMONIDINE TARTRATE: 5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0299-5980"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0299-5980
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6a4353f-ae69-4214-901f-e5d42a6fbde7